Elizabeth Masson-Hurlburt
Net Worth
Last updated:
What is Elizabeth Masson-Hurlburt net worth?
The estimated net worth of Ms. Elizabeth Masson-Hurlburt is at least $5,460,869 as of 14 Nov 2024. She owns shares worth $592,885 as insider, has earned $1,621,034 from insider trading and has received compensation worth at least $3,246,950 in CorMedix Inc..
What is the salary of Elizabeth Masson-Hurlburt?
Ms. Elizabeth Masson-Hurlburt salary is $463,850 per year as Executive Vice President & Head of Clinical Operations in CorMedix Inc..
How old is Elizabeth Masson-Hurlburt?
Ms. Elizabeth Masson-Hurlburt is 46 years old, born in 1979.
What stocks does Elizabeth Masson-Hurlburt currently own?
As insider, Ms. Elizabeth Masson-Hurlburt owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| CorMedix Inc. (CRMD) | Executive Vice President & Head of Clinical Operations | 45,397 | $13.06 | $592,885 |
What does CorMedix Inc. do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Elizabeth Masson-Hurlburt insider trading
CorMedix Inc.
Ms. Elizabeth Masson-Hurlburt has made 2 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently she sold 140,027 units of CRMD stock worth $1,565,642 on 14 Nov 2024.
The largest trade she's ever made was exercising 140,027 units of CRMD stock on 14 Nov 2024. As of 14 Nov 2024 she still owns at least 45,397 units of CRMD stock.
CorMedix key executives
CorMedix Inc. executives and other stock owners filed with the SEC:
- Dr. Matthew T. David M.D. (47) Interim Chief Executive Officer, Executive Vice President & Chief Financial Officer
- Dr. Phoebe Mounts Esq. (75) Executive Vice President, Gen. Counsel, Sec. and Head of Regulatory, Compliance & Legal
- Ms. Elizabeth Masson-Hurlburt (46) Executive Vice President & Head of Clinical Operations